STAAR Surgical Company
STAA
$18.03
$0.150.84%
NASDAQ
| 12/27/2024 | 09/27/2024 | 06/28/2024 | 03/29/2024 | 12/29/2023 | |
|---|---|---|---|---|---|
| Net Income | -34.23M | 9.98M | 7.38M | -3.34M | 7.76M |
| Total Depreciation and Amortization | 2.38M | 1.76M | 1.52M | 1.24M | 1.21M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.92M | 10.37M | 10.20M | 6.96M | 2.55M |
| Change in Net Operating Assets | 25.58M | -18.29M | -29.51M | 16.82M | 20.45M |
| Cash from Operations | 642.00K | 3.82M | -10.41M | 21.68M | 31.97M |
| Capital Expenditure | -5.73M | -6.23M | -6.24M | -5.20M | -3.09M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.77M | -29.01M | -14.43M | 21.39M | 25.49M |
| Cash from Investing | -19.50M | -35.24M | -20.67M | 16.19M | 22.40M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -41.00K | -42.00K | -42.00K | -40.00K | -40.00K |
| Issuance of Common Stock | 40.00K | 1.66M | 372.00K | 5.33M | 408.00K |
| Repurchase of Common Stock | -109.00K | 0.00 | -167.00K | -1.23M | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -110.00K | 1.62M | 163.00K | 4.06M | 367.00K |
| Foreign Exchange rate Adjustments | -881.00K | 1.04M | -330.00K | -937.00K | 868.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -19.84M | -28.77M | -31.25M | 40.99M | 55.61M |